Research programme: oncolytic viruses - TOT BiopharmAlternative Names: TOT 401; TVL 111; TVP 211
Latest Information Update: 24 Oct 2016
At a glance
- Originator TOT Biopharm
- Class Oncolytic viruses
- Mechanism of Action Gene transference
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 24 Oct 2016 Preclinical trials in Cancer in China (Parenteral) (TOT Biopharm pipeline, October 2016)
- 03 Dec 2012 Early research in Cancer in China (unspecified route)